Foundation system

The Lymphoma Research Foundation creates the Kanti R. Rai, MD Clinical Research Program for the ongoing study of chronic lymphocytic leukemia (CLL)

The Lymphoma Research Foundation announces the creation of the Kanti R. Rai, MD Clinical Investigator Program to fund the study of lymphoma and chronic lymphocytic leukemia (CLL).

NEW YORK, August 23, 2022 /PRNewswire-PRWeb/ — The Lymphoma Research Foundation (LRF) – the nation’s largest nonprofit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive suite of educational programs, outreach initiatives and patient services – today announced the creation of the Kanti R. Rai, MD Clinical Scholar program to fund the ongoing study of lymphoma and chronic lymphocytic leukemia (CLL). Created in recognition of Dr. Rai’s global leadership in the field of lymphoma/CLL research and his commitment to the mission of LRF, the first award associated with the program will be announced in the spring of 2023.

Dr. Rai has been a world leader in lymphoma and CLL research for over four decades. The staging system that bears his name grew out of his pioneering early work in the field and the publication of the Rai prognostic categorization of CLL in a landmark paper still used today by physicians and clinical researchers around the world. His research has led to the development of several innovative cancer therapies, transforming the way CLL is treated. He is currently a Professor in the Karches Center for Oncology Research at Northwell Health’s Feinstein Institutes for Medical Research, and is the Joel Finkelstein Cancer Foundation Professor of Medicine and Molecular Medicine at the Donald and Barbara Zucker School of Medicine in Northwell Health. Hofstra/Northwell. Elected to LRF’s prestigious Scientific Advisory Board (SAB) in 2007, Dr. Rai has helped shape LRF’s research portfolio and mentor the next generation of clinicians and LLC scientists.

Each year, LRF awards a participant in its Lymphoma Scientific Research Mentorship Program (LSRMP) the Kanti R. Rai, MD Clinical Scholar Award. As part of the Foundation’s LSRMP program, the recipient will become an LRF Fellow and benefit from mentorship from global lymphoma experts as they pursue a career in CLL research. The new grant will ensure the fellow’s participation in the two-year program, provide scientific support and funding for professional development.

“This investment in early career scientists will strengthen the lymphoma and CLL research pipeline for decades to come and will be instrumental in training the next generation of CLL experts,” said Meghan Gutierrez, CEO of the Lymphoma Research Foundation. “This level of ongoing support is essential for the study of rare cancers like CLL. The Lymphoma Research Foundation could think of no better way to recognize Dr. Rai’s career and leadership in CLL research than through the creation of this new program. , which will impact CLL patients here and around the world. »

Media Contact

Nichole MusumeciLymphoma Research Foundation, 9176921141, [email protected]

SOURCE Lymphoma Research Foundation